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ABSTRACT
Copper and tributyltin hydride catalysed cyclization, through the N-aryl bond formation, of imidazolidine-2,4-diones (11–16,18)
yielded imidazo[1,5-a]indole-1,3-diones (5–10) in high yields (72–100%). The ease of cyclization was found to be consistent with
the normal halogen reactivity and the type of substituents. The highly substituted imidazole-2,4-dione 15 gave brominated 19 and
tin incorporated heterocycles 20 when treated with copper bromide and tributyltin hydride, respectively.
KEYWORDS
Indoles, imidazolidine-2,4-diones, arylaldehyhydes, copper bronze, tributyl tin hydride.
1. Introduction
Indoles of varying complexity have profound biological
activity and significance in medicinal chemistry.1,2 For example,
amauromine is a vasodilator,3 while indomethacin is used in the
treatment of rheumatoid arthritis.4 5-N-acetylardeemin is one of
the most potent known agents for reversal of multiple drug
resistance,5 lysergic acid diethylamide is physiologically active
and indole-3-acetic acid has well-known plant growth regulatory
properties.4 Currently, intensive research to identify potent viable
drugs for management of AIDS has resulted into identifying
indoles to be among the non-nucleoside reverse transcriptase
inhibitors (NNRTI). In fact, the most effective anticancer and
anti-HIV drugs are derived from the indole basic structure, with
substituents in both the aromatic and heterocyclic rings.6–9
As a consequence of this widespread bioactivity, many methods
of indole synthesis have been developed. These methods can be
classified broadly into two categories: those in which the N-aryl
bond is established at an early stage and those involving the
N-aryl bond formation late in the synthesis. Superimposed onto
each of these is a strategy that depends upon assembly of the
benzenoid ring. The better known and more widely used
methods include the Fischer,10 Bischler,11 Reissert,12 Madelung,13
and Batcho-Leimgruber1 indole syntheses. In all the above
methods, the pyrrole ring is constructed by annulation on to an
appropriately nitrogen-substituted aromatic precursor. Thus the
bond between the nitrogen and the benzene ring is established
very early in the synthesis. There are few syntheses of indoles
that involve formation of the N-aryl bond. These include
Nenitzescu14 indole synthesis, copper catalysed ring closure,15
Bartoli synthesis16 and the Pd-catalysed tandem C-N/Suzuki-
Miyaura coupling.17
The search for an efficient synthesis of indoles has been a
problem for nearly a century in organic synthesis and only the
Batcho-Leimgruber1 method provides a general route for
synthesizing indoles, which are substituted on the benzene ring
but not on the heterocyclic nucleus. In our effort to contribute to
the synthesis of this class of compounds, we hereby present
a new, efficient method for synthesizing indoles that are
substituted in both the benzene and the heterocyclic rings, in
two steps. The steps involve the initial condensation of aromatic
aldehydes 1 with imidazolidine-2,4-diones18 2a and 2b followed
by cyclization of the generated 5-[phenylmethyledene]-
imidazolidine-2,4-diones 3,4 (Scheme 1). Cleavage of the
hydantoin ring can be a potential route to 2-substituted indoles.
This is important because indoles are more reactive at the
3-position, and will react at this position before substituents can
be added as electrophiles, to the 2-position.
2. Results and Discussion
It was anticipated that problems could arise during the
attempted cyclization due to the presence of two acidic NH
groups in imidazolidine-2,4-dione (hydantoin) itself. Though
the more acidic nitrogen at position 3 cannot be involved in
intramolecular cyclization, such acidic sites might lead to
intermolecular reactions and polymers.19 In order to overcome
these problems, imidazolidine-2,4-diones protected at position 3
were synthesized. The protecting groups used were the readily
available phenyl and methyl groups, though other protecting
groups have been reported.20
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Scheme 1
Synthesis of indoles.
The precursor, 3-phenylimidazolidine-2,4-dione 2a, was
synthesized from glycine and phenylisocyanate,21 while
3-methyl-1,3-diazolidine-2,4-dione 2b was prepared according
to the method of Harris and Weiss.22
Condensation reactions, between aldehydes and 2a, were
carried out under standard conditions of reflux in glacial acetic
acid, in the presence of potassium acetate and a little acetic
anhydride (Table 1).21,23 The assignment of geometric isomers
was carried out by comparing the chemical shifts of their olefinic
proton signals,23 and confirmed through Nuclear Overhauser
enhancement (NOESY) NMR experiments. The (Z)-isomer was
the major isomer, probably because it is thermodynamically
more stable than the (E)-isomer. Electron donating groups on the
aldehyde retard the initial addition process, while the same
groups speed the dehydration reaction up by stabilizing the
incipient cationic charge at the benzylic center.23 Thelower yields
of 13, 14, and 15 may be an indication that the first step, addition,
was rate limiting.
3-Methyl-1,3-diazolidine-2,4-dione 2b was condensed with
2-chlorobenzaldehyde, in the presence of potassium acetate and
a catalytic amount of acetic anhydride, to yield the intermediate
alcohol 17 as one stereoisomer. The reaction was repeated using
stoichiometric amounts of acetic anhydride to yield 18.
Copper-catalysed cyclization23,24 of 2-halo substrates, 11–15
and 18 under reflux conditions in quinoline gave, after work-up
and chromatographic purification, fluorescent products 5–9,
(Table 2). All the products showed a change from the olefinic
proton signal to a narrow aromatic doublet.23 Absence of the NH
signal in their 1H NMR spectra, was also used to confirm
cyclization.
The precise mechanism of cyclization is not known; however,
it probably involves an intermediate in which copper, via copper
(I), has inserted into the aryl halide bond, followed by a
nucleophillic substitution of the nucleophilic nitrogen group
(Scheme 2). Insertion of copper was part of the rate determining
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Table 1 Yield and isomer ratio of 5-[phenylmethyledene]imidazolidine-2,4-diones 11–16 and 18.
Substituent position
Product Time/h R’ R2” R3” R4” R5” %Yield (Z):(E)
11 8 Ph Br H H H 64 100:0
12 5 Ph Cl H H H 64 90:10
13 5 Ph Cl H OH H 24 100:0
14 16 Ph Br H OMe OMe 19 100:0
15 16 Ph Br OMe OMe OMe 34 100:0
16 5 Ph Cl H H NO2 61 90:10
18 a 16 Me Cl H H H 85 70:30
a A stochiometric amount of Ac2O.
Table 2 Yield and physical properties of imidazol[1,5-a]indole-1,3-diones 5–10.
Phenylmethyledeneimidazolidine-2,4-diones Time/h Imidazol[1,5-a]indole-1,3-dione m.p/°C Yield/%
11 2 5 198-200 80
12 0.2 5 198-200 72
13 1 6 248-249 100
14 0.3 7 244-246 98
15 1 8 210–212 50
18 1 9 243–245 75
16 b 0.5 10 258–260 73
b Cu/DMF.
Scheme 2
Proposed mechanism of cyclization.
step of the reaction, since hindrance about this center decreased
the yield, either through slower copper insertion or interferance
with ring closure of the aryl copper intermediate. The ease of
cyclization was consistent with the normal halogen reactivity of
the substrates.
Efforts to cyclize 16 under similar conditions were unsuccess-
ful and suggested that other factors might influence the reaction.
The solvent, quinoline, was replaced with dimethyl formamide
(DMF) and the reaction performed at reflux in the presence of
only a catalytic amount of copper bronze25 to give 10. Electron
withdrawing groups ortho- or para- to the halogen have been
known to hasten Ullmann reactions.24 Similar treatment of 15
gave the unexpected product 19, which might have been
derived from oxidative cyclization at the non-brominated
position.
Compounds 11, 12, and 14, were each treated at reflux temper-
ature with tributyltin hydride, in presence of AIBN as the radical
initiator, to yield 5 and 7 (Table 3). This result is consistent with
the lower reactivity of organochlorine compounds compared
with organobromine reactants in free radical reactions. Most
probably, an aryl radical was generated and would have under-
gone intramolecular cyclization.
The unique reaction of the 2-bromo-3,4,5-trimethoxy precursor,
15, was again demonstrated when this precursor yielded the
unexpected tin incorporated heterocycle, 20. In the 1H NMR
spectrum of 20, scalar coupling to the tin nucleus was only
observed for the H9 proton and not to the H4 proton. This
indicated that the molecule is planar and rigid, the path between
H9 and tin is a W-shape and should provide more favourable
coupling than the alternative path between H4 and the tin. The
13C NMR spectrum of 20, showed 27 signals. The signals at 26.0
and 27.7, corresponding to the methylene carbons attached to
the tin exhibited tin satellites (J 69.0, 22.6 Hz, respectively). The
most likely explanation for these latter observations was that 20
was in a conformationally locked, square planar arrangement
that made the butyl groups non-equivalent. Indeed tin is known
to exhibit either a tetrahedral or square planar conformation.
When the two butyl groups are non-equivalent, as observed for
20, it appears logic that tin should be in a planar conformation.
The exact conformation can only be determined using X-ray
crystallography. The N-phenyl ring was influenced by the tin
that all its carbons were now non-equivalent.
3. Experimental
3.1. General
Melting points were measured on a Reichert microscope and
are uncorrected. 1H NMR spectra were recorded in dimethyl
sulfoxide (DMSO) on a Bruker DMX 500 (500 mHz) Avance
instrument. Data are reported as follows: chemical shift (δ) in
ppm downfield from tetramethylsilane (TMS), number of
protons, multiplicity, observed coupling constant(s) (J in Hz)
and proton assignment. Multiplicities are reported as singlet (s),
broad singlet (br s), doublet (d), broad doublet (br d), doublet of
doublets (dd), triplet (t), multiplet (m). The 13C NMR spectra
were also recorded on a Bruker AC 300F spectrometer at
75.06 mHz and are reported in ppm downfield from TMS. The
electron impact (EI) mass spectra were recorded on a VG
Quattro mass spectrometer with an ionizing potential of 70 eV
and an ion source temperature of 220°C. The principal ion peaks
m/z are reported together with their percentage intensities
relative to the base peak. HRMS were recorded on a Bruker
Daltonics (Bellerica, MA), BiopAPEX II 7T FT/ICR mass
spectrometer.
3-Phenylimidazolidine-2,4-dione (2a)23,26
Glycine (7.5 g g, 0.13 mol) was dissolved into a solution of KOH
(6.80 g) in water (40 mL) and the mixture cooled in ice.
Phenylisocyanate (13.20 g, 0.11 mol) was added dropwise to
the stirred solution. Upon standing overnight, the mixture
deposited a precipitate (2.00 g) that was collected and identified
as diphenyl urea m.p. 235–237°C, (lit.26 m.p. 239–241°C). The
filtrate was acidified to yield another precipitate which was
collected, drained at the pump, then refluxed with a mixture
of water (20 mL) and HCl (50%, 20 mL) for 1 h. The resulting
solution was cooled to room temperature and the crystalline
precipitate was collected. Further recrystallization from ethanol
gave 2a as white needles (11.60 g, 66%, m.p. 153–154°C (lit.26 m.p.
154–155°C).
3.2. Condensation Reactions of 2a with Aldehydes
General Procedure for Condensation Reactions26
Molar equivalents of compound and the aldehydes, anhy-
drous NaOAc or KOAc, glacial AcOH and Ac2O (3 drops) were
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Table 3 Yield of imidazol[1,5-a]indole-1,3-diones 5 and 7 using tributyl tin hydride.
Phenylmethyledeneimidazolidine-2,4-diones Time/h Imidazol[1,5-a]indole-1,3-dione Yield/%
11 3 5 99
12 8 5 68
14 3 7 89
dissolved together at r.t. and the mixture warmed to reflux
temperature. Reactions were monitored by thin layer chromato-
graphic analysis until all the aldehyde had reacted. Upon




Bromobenzaldehyde (4.00 g, 21.6 mmol) reacted after 8 h to
give a yellow solid (5.00 g) that was shown by 1H NMR to be
isomerically pure. Recrystallization from AcOH gave 11 as white
needles (4.88 g, 64%), m.p. 240–242°C; δH (500 MHz, DMSO-d6)
6.70 (1H, s, 1’-H), 7.29 (2H, dd, J 8.2, 2.0 Hz, 4”-H and 5”-H),
7.40–7.50 (4H, m, 2”’-H to 6”’-H), 7.75 (2H, dd J 8.2, 2.0 Hz, 3”- and
6”-H), 11.13 (1H, br s, 1-NH); δC (500 MHz, DMSO-d6 107.6 (C-1’),
124.5 (C-2”), 127.2 (C-2”’ and C-6”’), 128.4 (C-5), 128.5 (C-4”’),
129.0 (C-5”), 129.2 (C-3”’ and C-5”’), 130.7 (C-6”), 130.8 (C-1”),
132.0 (C-4”), 132.1 (C-1’”), 132.9 (C-3”), 154.4 (C-2), 163.3 (C-4);
m/z 345 (M(81Br)+1, 4%), 344 (M(81Br)+, absent), 343 (M(79Br)+1,
4), 265 (4), 264 (22), 263 (100), 262 (6), 195 (6), 144 (3), 132 (5), 119
(24), 115 (39), 114 (16), 89 (40), 77 (17), 65 (7), 63 (16), 51 (4); (Found:




2-Chlorobenzaldehyde (5.00 g, 36 mmol) reacted after 5 h to
give a yellow solid (4.90 g). Recrystallization from EtOH gave a
90:10 mixture of (Z)- and (E)-12 as white needles (4.73 g, 64%),
m.p. 250–252°C (lit.25 252–253°C).
5-[(Z)-1-(2-Chloro-4-hydroxyphenyl)methylidene]-3-phenyl-
imidazolidine-2,4-dione (13)
2-Chloro-4-hydroxybenzaldehyde, (2.00 g, 13 mmol), reacted
after 5 h to give a yellow solid (0.94 g) that was identified by 1H
NMR as a single isomer. Recrystallization from AcOH gave 13 as
yellow needles (0.78 g, 24%), m.p. 240–242°C; δH (500 MHz,
DMSO-d6) 6.73 (1H, s, 1’-H), 6.83 (1H, dd, J 8.6, 2.5 Hz, 5”-H), 6.95
(1H, d, J 2.5 Hz, 3”-H), 7.41–7.52 (4H, m, 2”’-H to 6”’-H), 7.67 (1H,
d, J 8.6 Hz; 6”-H), 10.35 (1H, br s, 1-NH), 10.97 (1H, s, 4”-OH);
δc(500 MHz, DMSO-d6) 105.7 (C-1’), 115.2 (C-5”), 116.6 (C-3”),
121.7 (C-1”), 126.6 (C-4’”), 127.3 (C-2”’ and C-6”’), 128.2 (C-5),
129.2 (C-3”’ and C-5”’), 131.3 (C-6”), 132.1 (C-1’”), 134.7 (C-2”),
154.4 (C-2), 159.1 (C-4”), 163.3 (C-4); m/z: 316 (M+1, 0.3%), 315
(M+, 0.5), 279 (39), 168 (6), 167 (18), 166 (15), 130 (130), 119 (80), 105
(32), 91 (100), 77 (58), 76(31), 65 (22) 64 (45), 63 (31), 51 (42);




2-Bromo-4,5-dimethoxybenzaldehyde reacted after 16 hours
to give a yellow solid (3.00 g) that was collected and shown by 1H
NMR to be isomerically pure. Recrystallization from MeOH
gave 14 as yellow needles (2.90 g, 19%), m.p. 288–290°C; δH
(500 MHz, DMSO-d6) 3.80 (3H, s, 5”-OCH3), 3.87 (3H, s,
4”-OCH3), 6.63 (1H, s, 1’-H), 7.14 (1H,s, 6”-H), 7.25 (1H, s, 3”-H),
7.42 (2H, tm, J 7.2 Hz, 2”’-H and 6”’-H), 7.47 (1H, tm, J 7.2 Hz,
4”’-H), 7.56 (2H, tm, J 7.2 Hz, 3”’-H and 5”’-H), 11.11 (1H, br s,
NH); δC (500 MHz, DMSO-d6) 56.0 (4”-OCH3), 56.4 (5”-OCH3),
108.6 (C-1’), 112.8 (C-6”), 115.7 (C-2”), 116.0 (C-3”), 124.7 (C-1”),
127.3 (C-2”’ and C-6”’), 127.5 (C-4’”), 128.4 (C-5), 129.2 (C-3”’ and
C-5”’), 132.1 (C-1’”), 148.5 (C-4”), 150.2 (C-5”), 154.4 (C-2), 163.3
(C-4); m/z 404 (M+, 5%), 325, (5), 324 (10), 323 (100), 307 (10), 279
(5), 240 (5), 176 (5), 162 (10), 149 (5), 133 (5), 119 (10), 102 (5), 91 (10),
77 (10), 63 (10), 51 (3). (Found: C, 53.82; H, 3.87; N, 6.75.
C18H15BrN2O4 requires: C, 53.61; H, 3.74; N, 6.94%).
5-[(Z)-1-(2-Bromo-3,4,5-trimethoxyphenyl)methylidene]-3-phenyl-
imidazolidine-2,4-dione (15)
2-Bromo-3,4,5-trimethoxybenzaldehyde reacted after 16 h to
give a yellow solid (3.65 g) that was shown by 1H NMR to be
isomerically pure. Recrystallization from MeOH gave 15 as
yellow needles (3.50 g, 34%), m.p. 260–262°C; δH (500 MHz,
DMSO-d6) 3.79 (3H, s, 4”-OCH3), 3.80 (3H, s, 3”-OCH3), 3.91 (3H,
s, 5”-OCH3), 6.61 (1H, s, 1’-H), 7.16 (1H, s, 6”-H), 7.33–7.52 (5H, m,
2”’-H to 6”’-H), 11.20 (1H, br s, NH); δC (500 MHz, DMSO-d6) 56.4
(5”-OCH3), 61.2 (3”-OCH3 and 4”-OCH3), 107.7 (C-1’), 109.6
(C-6”), 110.8 (C-2”), 127.2 (C-2”’ and C-6”’), 128.3 (C-5), 128.8
(C-4”’), 129.2 (C-3”’ and C-5”’), 129.9 (C-1”’), 132.3 (C-1”), 143.1
(C-4”), 150.9 (C-2), 152.9 (C-3”), 155.0 (C-5”), 163.7 (C-4); m/z 434
(M+ (81Br), 5%), 432 (m(79Br), 5), 354 (30), 353 (100), 323 (10), 292
(15), 176 (22), 120 (10), 119 (22); (Found: C, 52.00; H, 3.70; N, 6.30.
C19H17BrN2O5 requires: C, 52.70; H, 4.00; N, 6.50%).
5-[(Z)-and (E)-1-(2-Chloro-5-nitrophenyl)methylidene]-
3-phenylimidazolidine-2,4-dione (16)
2-Chloro-5-nitrobenzaldehyde (4.60 g, 25 mmol), reacted after
5 h to give a white solid (5.60 g). Recrystallization from acetic acid
gave a 60:40 mixture (Z):(E) isomers of 16 as white needles
(5.30 g, 61%), m.p. 205–206°C; δH (500 MHz, DMSO-d6) 6.49 (1H,
s, 1’-H, E-isomer), 6.60 (1H, s, 1’-H, Z-isomer), 7.33–7.53 (4H, m,
2”’-H to 6”’-H), 7.80 (1H, d, J 8.7 Hz, 3”-H), 8.17 (1H, dd, J 8.7,
2.6 Hz, 4”-H), 8.45 (1H, d, J 2.6 Hz, 6”-H), 9.12 (1H, br s, 1-NH,
Z-isomer), 9.50 (1H, br s, 1-NH, E-isomer); δC (500 MHz,
DMSO-d6) 102.6 (C-1’); 124.4 (C-4”), 125.6 (C-6”), 125.7 (C-5);
127.2 (C-2”’ and C-6”’); 128.5 (C-4”’); 129.2 (C-3”’ and C-5”’); 131.1
(C-1’”); 132.1 (C-3”); 133.1 (C-1”); 139.7 (C-2”); 146.9 (C-5”); 154.8
(C-2); 163.2 (C-4); m/z 346 (M(37Cl)+1, 0.5%), 345 (M(37Cl)+, 0.4), 344
(M(35Cl)+1, 0.2), 343 (M(35Cl)+1, 0.4), 308 (7), 262 (3), 196 (5), 179
(6), 150 (18), 125 (20), 123 (64), 119 (42), 114 (38), 91 (100), 77 (92), 65
(38), 64 (55), 63 (55), 51 (63); (Found: C, 55.88; H, 3.14; N, 12.16.
C16H10ClN3O4 requires: C, 55.90; H, 2.91; N, 12.22%).
3-Methyl-1,3-diazolidine-2,4-dione (2b)22
Imidazolidine-2,4-dione (8.00 g, 0.04 mol) and dimethyl sulfate
(10.00 g, 0.04 mol) were dissolved in NaOH (50 mL, 2 M) and the
solution stirred at r.t. overnight. The mixture was poured into
water (50 mL) and neutralized with HCl (2 M). The resulting
solution was extracted with EtOAc (3 × 20 mL) and the
combined organic extracts dried over MgSO4. Excess solvent was
evaporated off under reduced pressure to afford a white solid
(2.70 g). The solid was recrystallized from EtOH to give 2b as




Diazolidine 2a (1.00 g, 0.877 mmol), 2-chlorobenzaldehyde
(1.50 g, 1.07 mmol), KOAc (3.00 g), Ac2O (3 drops) were heated at
reflux for 8 h. Upon cooling the reaction mixture gave a white
solid which was recrystallized from EtOH to afford 17 as white
needles (0.15 g, 67%), m.p. 212–213°C; δH (500 MHz, DMSO-d6)
2.83 (3H, s, CH3), 4.24 (1H, s, OH), 5.28 (1H, dd, J 5.6, 3.0 Hz, 1’-H),
5.90 (1H, d, J 5.6, 5-H), 7.32–7.35 (3H, m, 4”-H to 6”-H), 7.60 (1H,
dd, J 7.2, 2.0 Hz, 3”-H), 7.80 (1H, br s, NH); δC (500 MHz,
DMSO-d6) 24.2 (CH3), 60.9 (C-1’), 67.7 (C-5), 127.5 (C-6”), 129.0
(C-3”, C-4” and C-5”), 130.5 (C-1”), 138.7 (C-2”), 158.1 (C-2) 172.7
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(C-4); m/z 257 (M(37Cl)+1, 0.8), 256 (M(37Cl)+1, 0.5), 255 (M(35Cl)+1,
2%) 254 (M(35Cl)+1, absent), 239 (0.8), 237 (2), 201 (21), 177 (9), 176
(70), 143 (10), 141 (36), 120 (14), 119 (49), 114 (100), 113 (28), 77 (19),
51 (24); (Found: C, 51.96; H, 4.20; N, 11.03. C11H11ClN2O3 requires:
C, 51.96; H, 4.31; N, 10.98%).
5-[(Z)- and (E)-1-(2-chlorophenyl)methylidene]-3-methyl-
imidazolidine-2,4-dione (18)27
The reaction was repeated with a volumetric amount of Ac2O
(5 mL) and the reaction heated at reflux for 16 h. Upon cooling a
white solid was obtained that was recrystallized from EtOH to
afford 70: 30 mixture of (Z)- and (E)-18 as white needles (0.18 g, 85
%), m.p. 198–200°C. (lit.27 m.p. 229–230°C).
3.3. Copper Catalysed Cyclization
General Procedure for Cyclizations23
The 5-[(phenyl)methylidene]-3-phenylimidazolidine-
2,4-diones (2 mmol), copper bronze (0.05 g) and quinoline (5 mL)
were refluxed together in a Wood’s metal bath and the reaction
monitored by TLC for the disappearance of the starting material.
Upon completion of the reaction, the mixture was cooled to
approximately 150°C, and filtered to remove copper salts. The
warm residue was washed with hot EtOH (10 mL) and the
filtrate washings combined, evaporated under reduced pressure
and diluted with aq. HCl (10 mL, 10%) to give a solid that was
subjected to column chromatography on silica gel eluted with
(1:1) EtOAc-light petroleum to afford the indoles.
2-Phenyl-2,3-dihydro-1H-imidazol[1,5-a]indole-1,3-dione (5)28
Compound 11 (0.50 g, 1.40 mmol) reacted, in a Wood’s metal
bath at 200°C, within 2 h to give indolo 13 as white needles
(0.29 g, 80%), m.p. 198–200°C (lit.28 m.p. 212–213°C).
6-Hydroxy-2-phenyl-2,3-dihydro-1H-imidazol[1,5-a]indole-
1,3-dione (6)
Compound 13 (0.2 g, 0.63 mmol) reacted, in a Wood’s metal
bath at 180°C, within 1 h to afford 6 as yellow needles (0.16 g, 100
%), m.p. 248–249°C; δH (500 MHz, DMSO-d6) 6.84 (1H, dd, J 8.2,
2.0 Hz, 7-H), 7.20 (1H, d, J 2.0 Hz, 5-H), 7.34 (1H, s, 8-H), 8.42-7.52
(5H, m, 2’-H to 6’-H), 7.64 (1H, d, J 8.2 Hz, 9-H), 10.32 (1H, s, OH),
δC (500 MHz, DMSO-d6) 98.5 (C-5), 110.1 (C-9), 114.6 (C-7), 125.1
(C-8a), 125.8 (C-9), 127.2 (C-2’ and C-6’), 127.6 (C-4’), 128.6 (C-3’
and C-5’), 129.1 (C-9a), 131.9 (C1’), 134.2 (C-4a), 148.1 (C-3), 158.2
(C-1), 159.2 (C-6); m/z: 279 (M+1, 14%), 278 (M+, 73), 277 (4), 160
(14), 159 (100), 158 (8), 132 (50), 131 (31), 130 (24), 119 (26), 103 (13),
91 (14), 76 (17), 64 (15), 51 (13); (Found: m/z 301.05870.




Compound 14 (0.5 g, 1.23 mmol) reacted, in a Wood’s metal
bath at 180°C, within 0.5 h to give indole 7 as yellow needles
(0.39 g, 98%), m.p. 244–246°C; δH (500 MHz, DMSO-d6) 4.21 (3H,
s, 7-OCH3), 4.38 (3H, s, 6-OCH3), 7.25 (1H, s, 5-H), 7.30 (1H, s,
9-H), 7.37 (1H, s, 8-H), 7.43-7.57 (5H, m, 2’-H to 6’-H); δC
(500 MHz, DMSO-d6) 56.0 (7-OCH3), 56.2 (6-OCH3), 95.6 (C-5),
105.4 (C-9), 109.5 (C-8), 125.0 (C-4a), 127.2 (C-2’ and C-6’), 127.6
(C-8a), 127.8 (C-4’), 128.3 (C-3’ and C-5’), 129.2 (C-3a), 131.8
(C-1’), 147.5 (C-7), 148.0 (C-3), 151.7 (C-6), 158.1 (C-1); m/z 324
(M+, absent), 323 (22%), 322 (84), 321 (4), 204 (13), 203 (100), 192
(10), 175 (22), 160 (22), 145 (10), 132 (18), 119 (55), 117 (51), 102 (19),
91 (34), 89 (19), 77 (18), 76 (7), 63 (17), 50 (7); (Found: C, 66.98; H,
4.45; N, 8.50. C18H14N2O14 requires: C, 67.07; H, 4.38; N, 8.69%).
2-Phenyl-5,6,7-trimethoxy-2,3-dihydro-1-imidazol[1,5-a]indole-
1,3-dione (8)
Compound 15 (0.5 g, 1.16 mmol) reacted, in a Wood’s metal
bath at 180°C, within 0.5 h to give indolo 8 as yellow needles,
(0.20 g, 50%), m.p. 210–212°C; δH (500 MHz, DMSO-d6) 3.83 (3H,
s, 5-OCH3), 3.85 (3H, s, 6-OCH3), 3.86 (3H, s, 6-OCH3), 6.88 (1H, s,
8-H), 7.38 (1H, s, 9-H), 7.47-7.25 (5H, m, 2’-H to 6’-H); δC
(500 MHz, DMSO-d6) 56.5 (5-OCH3), 61.4 (6-OCH3), 62.8
(7-OCH3), 101.9 (C-8), 109.4 (C-9), 122.7 (C-4a), 127.8 (C-2’ and
C-3’), 128.7 (C-9a), 129.0 (C-4’), 129.2 (C-3’ and C-5’), 130.1 (C-8a),
132.1 (C-1’), 141.0 (C-5), 144.2 (C-6), 146.8 (C-3), 151.8 (C-7), 158.2
(C-1); m/z 352 (M+, 44%), 338 (24), 233 (100), 218 (22), 204 (48), 201
(19), 190 (20), 146 (10), 129 (30), 121 (35), 106 (10), 93 (20), 69 (22), 57
(22); (Found: C, 64.60; H, 4.30; N, 7.60. C19H16N2O5 requires: C,
64.80; H, 4.60; N, 7.90%).
2-Methyl-2,3-dihydro-1H-imidazol[1,5-a]indole-1,3-dione (9)
Compound 18 (0.20 g, 0.084 mmol) reacted, in a Wood’s metal
bath at 180°C, within 1 h to give 9 as white needles (0.10 g, 75%),
m.p. 243–245°C; δH (500 MHz, DMSO-d6) 3.02 (3H, s, CH3),
7.31(1H, δ, J 7.1, 2.0, 1.0 Hz, 7-H), 7.34 (1H, d, J 1.0 Hz, 9-H), 7.52
(1H, δ, J 7.1, 2.0, 1.0 Hz, 5-H), 7.76 (1H, δ, J 7.1, 2.0, 1.0 Hz, 6-H),
7.78 (1H, δ, J 7.1, 2.0, 1.0 Hz, 8-H); δC (500 MHz, DMSO-d6) 32.7
(CH3), 116.1 (C-9), 120.6 (C-5), 131.9 (C-7), 132.5 (C-8), 136.3 (C-6),
137.5 (C-4a), 140.2 (C-8a), 140.4 (C-9a), 149.5 (C-3), 159.3 (C-1).
m/z: 201 (M+1, 4%), 200 (M+, 39), 144 (6), 143 (96), 116 (5), 115
(100), 100 (4), 89 (4), 88 (20), 62 (12), 56 (8), 50 (5), 43 (4); (Found: C,




Compound 16 (0.500 g, 1.45 mmol), reacted in DMF to afford 10
as gray platelets (0.30 g, 73 %), m.p. 258–260°C; δH (500 MHz,
DMSO-d6) 7.28–7.38 (5H, m, 2’-H to 6’-H), 7.67 (1H, s, 9-H), 8.04
(1H, d, J 9.0 Hz; 5-H), 8.40 (1H, dd, J 9.0, 2.0 Hz, 6-H), 8.82 (1H, d, J
2.0 Hz, 8-H); δC (500 MHz, DMSO-d6) 109.3 (C-9), 113.7 (C-5),
121.3 (C-8), 123.6 (C-6), 127.7 (C-2’ and C-6’), 129.1 (C-4’), 129.5
(C-3’ and C-5’), 131.4 (C-9a), 132.0 (C-1’), 132.5 (C-8a), 135.2
(C-4a), 144.2 (C-7), 147.9 (C-3), 158.0 (C-1); m/z 308 (M+1, 7%),
307 (M+, 44), 189 (47, 188 (74), 187 (7), 172 (5), 158 (20), 130 (30), 114
(100), 102 (29), 91 (20), 87 (18), 81 (11), 63 (21), 51 (7), 43 (14);
(Found: C, 62.19; H, 2.90; N, 13.61. C16H9N3O4 requires: C, 62.54,
H, 2.95, N, 13.68%).
8-Bromo-2-phenyl-5,6,7-trimethoxy-2,3-dihydro-1H-imidazol[1,5-a]
indole-1,3-dione (19)
Compound 15 (0.10 g), CuBr (0.05 g) in dry DMF were refluxed
together for 2 h. On cooling, the blue solid was filtered off and
the filtrate was poured into H2O. The aq. phase was extracted
with EtOAc (3 × 10 mL). The combined organic extracts were
dried over MgSO4 and the solvent evaporated off to give a
yellow solid that was recrystallized from AcOH to afford 20 as
yellow needles (0.09 g, 90%), m.p. 148–150°C; δH (500 MHz,
DMSO-d6) 3.85 (3H, s, 6-OCH3), 3.87 (3H, s, 7-OCH3), 3.97 (3H, s,
5-OCH3), 6.94 (1H, s, 9-H), 7.35 (2H, tt, J 7.2, 2.0 Hz, 2’-H and
6’-H), 7.45 (1H, tt, J 7.2, 2.0 Hz, 4’-H), 7.55 (2H, tt, J 7.2, 2.0 Hz, 3’-H
and 5’-H), δC (500 MHz, DMSO-d6) 56.7 (6-OCH3),61.5 (7-OCH3),
62.9 (5-OCH3), 93.4 (C-8), 99.1 (C-9), 119.6 (C-9a), 127.8 (C-2’ and
C-6’), 128.2 (C-8a), 128.8 (C-4’), 129.3 (C-3’ and C-5’), 131.8 (C-1’),
141.1 (C-7), 145.0 (C-6), 144.5 (C-4a), 146.1 (C-3), 151.5 (C-5), 152.5
(C-1); m/z 433 (M(81Br)+1, 8%), 432 (M(81Br)+, 39), 431 M(79Br)+1,
8), 430 M(79Br)+, 39), 386 (6), 368 (8), 314 (12), 313 (100), 311 (99),
310 (13), 296 (13), 282 (37), 267 (18), 255 (10), 238 (17), 224 (13), 210
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(7), 182 (7), 161 (7), 146 (16), 131 (9), 119 (38), 114 (17), 91 (29), 83
(19), 69 (11), 55 (11), 43 (11); (Found: C, 52.99; H, 3.32; N, 6.64.
C19H115BrN2O5 requires: C, 52.92; H, 3.51; N, 6.50%).
3.4 Radical Promoted Cyclization of 11, 12 and 14
General Procedure for Radical Cyclization29
Bu3SnH (1.5 mol. equiv of 97%) was added dropwise by
syringe to the solution of the imidazolidine-2,4-dione and AIBN
(0.05 g) in dry PhCH3 (5 mL) under argon and the mixture heated
at reflux. The reactions were monitored by TLC. Upon comple-
tion the solutions were poured into aq. KF solution (50%, 50 mL)
and stirred at r.t. overnight. The aqueous layer was extracted
with CH2Cl2 (3 × 20 mL). The combined extracts were further
washed with aq. NaOH and dried over MgSO4. Excess solvent
was removed under reduced pressure and the residue subjected
to column chromatography on silica gel eluted with (1:1)
EtOAc-light petroleum to afford the respective indoles. Deriva-
tives 11 and 12 reacted, after 3 h, to afford 5 as white crystals (99,
68%, respectively), while derivative 14 (1.00 g, 2.90 mmol)
reacted, after 3 h, to afford 7 (89%).
5,5-Dibutyl-6,7,8-trimethoxy-2-phenyl-1,2,3,5-tetrahydroimidazo-
5-stanna-[1,5-b]isoquinoline-1,3-dione (20)
Compound 15 (1.50 g, 3.50 mmol) reacted to afford, after 3 h, 20
as white needles (1.50 g, 77%), m.p. 98–100°C; δH (500 MHz,
DMSO-d6) 0.80 (6H, t, J.7.5 Hz, 4”-CH3), 1.29 (4H, m, 3”-CH2), 1.57
(4H, m, 1”-CH2), 1.48 (4H, br m, 2”-CH2), 3.78 (3H, s, 7-OCH3),
3.83 (3H, s, 8-OCH3), 3.92 (3H, s, 6-OCH3), 6.53 (1H, s, 4-H), 7.21
(1H, t, JSn 18.0 Hz, 9-H), 7.40, (1H, tm, J 7.2 Hz, 4’-H), 7.46 (2H, tm J
7.2 Hz, 2’-H and 6’-H), 7.48 (2H, tm, J 7.2 Hz, 3’-H and 5’-H); δC
(500 MHz, DMSO-d6) 13.7 (C-4”), 16.0 (C-3”), 26.0 (t, JSn 69.0 Hz,
C-2”), 27.7 (t, JSn 22.6 Hz, C-1”), 56.5 (8-OCH3), 60.8 (6-OCH3), 61.3
(7-OCH3), 110.2 (C-4), 113.0 (C-9), 121.6 (C-6a), 126.4 (C-2’ and
C-6’), 128.0 (C-4’), 129.2 (C-3’ and C-5’), 132.3 (C-3a), 132.8 (C-1’),
135.5 (C-4a), 140.0 (C-7), 155.2 (C-6), 155.7 (C-8), 158.2 (C-1), 165.1
(C-3); m/z 586 (M+2, 3%), 584 (M+, 1), 582 (3), 529 (6), 473 (5), 457
(3), 308 (2), 280 (2), 120 (3), 119 (9), 91 (10), 81 (10), 69 (43), 57 (77),
55 (30), 41 (100); (Found: C, 55.58; H, 5.88; N, 4.82. C27H34N2O5Sn
requires: C, 55.51; H, 5.69; N, 4.79%).
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